CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC

Company

ASTRAZENECA PLC

Filed

December 27, 2004

Accession Number

0000950123-04-015235

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →